CLSD
Clearside Biomedical, Inc.
Total Trades
24
Buys
11
Sells
10
Largest Trade
N/A
Insiders
8
Institutional Funds
4
Inst. Value
$50K–$100K
Activist Filings
10
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Thorp Clay | Director | BUY | $1K–$15K | 15K | $0.92 | Feb 24, 2025 |
| Chong Ngai Hang Victor | Chief Medical Offi… | BUY | $15K–$50K | 37K | $1.00 | Nov 4, 2024 |
| Chong Ngai Hang Victor | Chief Medical Offi… | BUY | $15K–$50K | 24K | $1.06 | Jun 24, 2024 |
| Gibney Anthony S | Director | BUY | $100K–$500K | 100K | $1.30 | Apr 19, 2024 |
| Chong Ngai Hang Victor | CHIEF MEDICAL OFFI… | BUY | $15K–$50K | 30K | $1.60 | Mar 20, 2024 |
| WHITMORE BRADFORD T | 10% Owner | BUY | $500K+ | 444K | $1.35 | Feb 9, 2024 |
| LASEZKAY GEORGE M | CEO | SELL | $15K–$50K | 18K | $1.27 | Jan 19, 2024 |
| Deignan Charles A. | CFO | SELL | $15K–$50K | 13K | $1.28 | Jan 19, 2024 |
| WHITMORE BRADFORD T | 10% Owner | BUY | $50K–$100K | 136K | $0.74 | Nov 1, 2023 |
| Hutson Nancy J | Director | BUY | $1K–$15K | 10K | $0.86 | Oct 4, 2023 |
| Thorp Clay | Director | BUY | $1K–$15K | 10K | $0.86 | Sep 25, 2023 |
| Ciulla Thomas | Chief Medical Offi… | SELL | $15K–$50K | 14K | $1.47 | Jan 20, 2023 |
| LASEZKAY GEORGE M | CEO | SELL | $15K–$50K | 20K | $1.46 | Jan 20, 2023 |
| Deignan Charles A. | CFO | SELL | $15K–$50K | 14K | $1.50 | Jan 20, 2023 |
| Ciulla Thomas | Chief Medical Offi… | SELL | $1K–$15K | 2K | $1.62 | Jan 11, 2023 |
| Thorp Clay | Director | BUY | $1K–$15K | 14K | $1.02 | Dec 21, 2022 |
| Hutson Nancy J | Director | BUY | $15K–$50K | 30K | $1.33 | Nov 21, 2022 |
| Deignan Charles A. | CFO | GRANT | N/A | 44K | — | Jan 21, 2022 |
| Deignan Charles A. | CFO | SELL | $15K–$50K | 9K | $2.09 | Jan 21, 2022 |
| Ciulla Thomas | Chief Medical Offi… | SELL | $15K–$50K | 9K | $2.13 | Jan 21, 2022 |
| Ciulla Thomas | Chief Medical Offi… | GRANT | N/A | 44K | — | Jan 21, 2022 |
| LASEZKAY GEORGE M | CEO | SELL | $15K–$50K | 11K | $2.12 | Jan 21, 2022 |
| LASEZKAY GEORGE M | CEO | GRANT | N/A | 98K | — | Jan 21, 2022 |
| LASEZKAY GEORGE M | CEO | SELL | $1K–$15K | 5K | $2.46 | Jan 13, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Sep 30, 2025 · 4 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Apollon Wealth Management, LLC | 12K | $15K–$50K | SH |
| Apollon Wealth Management, LLC | 12K | $15K–$50K | SH |
| CIBC Private Wealth Group LLC | 73 | <$1K | SH |
| FINANCIAL CONSULATE, INC | 66 | <$1K | SH |
| JPMORGAN CHASE & CO | 13 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Apr 1, 2025
5.2%
4.0M shares
SC 13G/A · Mar 4, 2025
8.6%
6.5M shares
Hatteras Venture Advisors IV SBIC, LLC
SC 13D/A · Feb 21, 2025
0.0%
0 shares
SC 13G/A · Nov 1, 2023
10.1%
6.3M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 13, 2023
4.0%
2.4M shares
20-4822068 Hatteras Venture Advisors III, LLC
SC 13D/A · Jan 4, 2023
0.0%
0 shares
SC 13G/A · Jan 4, 2023
9.9%
6.0M shares
SC 13G/A · Feb 14, 2022
6.4%
3.8M shares
SC 13G/A · Jan 24, 2022
9.9%
5.9M shares